Adenosine Signaling During Post-Infarction Remodeling and Heart Failure
Adenosine Signaling During Post-Infarction Remodeling and Heart Failure
批准号:
9317191
负责人:
JOHN A AUCHAMPACH
金额:
$44.77万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-02-15 至 2021-01-31
关键词:
ADORA2B geneActivation AnalysisAcute myocardial infarctionAddressAdenosineAdenosine A2B ReceptorAmericanBiological AssayBiologyCardiacCardiac MyocytesCardiovascular systemCell SurvivalCellsChronicChronic lung diseaseCicatrixClinicalCoronary ArteriosclerosisCoronary arteryCoupledDataDiseaseExcisionExperimental Animal ModelExposure toFamilyFibroblastsFibrosisFunctional disorderG alpha q ProteinGene TargetingGeneticGenetsHeartHeart failureInfarctionInfiltrationInflammationInflammation MediatorsInflammatoryKidneyKidney DiseasesKineticsLigationLinkLiverLiver diseasesLungMacrophage ActivationMediator of activation proteinMicrodialysisModelingMolecular AnalysisMusMuscleMyelogenousMyocardial InfarctionMyocardial IschemiaMyocardiumOrganPathogenesisPathologicPathway interactionsPatientsPharmacologyPharmacotherapyPopulationProcessProductionPurinergic P1 ReceptorsRattusRecurrenceResearch Project GrantsRoleSignal TransductionSkinSonSurvival RateSymptomsTechniquesTestingTherapeutic InterventionTimeTissuesWorkadenosine deaminasebaseblood pumpcytokineexperienceextracellularhealingimprovedinjuredinterstitialmacrophagemembermouse modelmutantnew therapeutic targetnovelnovel therapeuticspreventrepairedresponseskin disordertissue repair
中文摘要
摘要
心肌梗死后组织间质腺苷浓度仍升高,损伤组织后仍持续。
已经痊愈,并形成了一道伤疤。然而,腺苷信号在心肌梗死后重塑中的作用
慢性缺血性心力衰竭仍不清楚。在其他器官中,出现了一个新的概念
如果腺苷通过激活促性腺激素的通路在组织中持续升高,则会造成损害
纤维化症。在慢性肺、肝、肾和皮肤病的实验动物模型中观察到了这一点。
艾斯。虽然腺苷造成损害的机制各不相同,但它通常会促进EXCES-
通过激活A2BAR进行组织修复。A2BAR是AR家族中独一无二的成员,拥有丰富的
在巨噬细胞中受压,与细胞激活和炎症/纤维化细胞因子的产生有关。至
确定腺苷信号在心肌梗死后重塑中的作用,我们检测了基因-
永久性冠状动脉结扎小鼠模型中A2BAR(ATL-801)的IC缺失或阻断。我们的
初步数据显示,心肌梗死后8周,肝纤维化明显减少,A2BAR信号丢失
与心脏组织炎症/纤维化活动减少、功能障碍减轻和改善有关
合规性。中心假说:心肌梗死后腺苷的产生持续增加,这对
通过激活A2BAR亚型导致纤维化、病理性重构和心力衰竭。目标1将定义
A2BAR信号在心肌梗死后重构中的作用。我们将测试基因缺失或抑制
A2BAR将减缓MI后存活心肌的纤维化发展速度,从而减少功能障碍。
并最终延长存活时间。这一目的也将使用ATL-801,Adora2b-/-小鼠来实现
作为本实验室培育的Adora2b突变大鼠新品系。目标2:描述通过什么机制
A2BAR信号参与了心肌梗死后的不良重构。利用有条件的靶向鼠标线缺失-
A2BAR在髓系细胞中的表达,巨噬细胞渗透/激活的评估,以及
对心肌梗塞后心脏组织的分子分析,我们将检验持续暴露于腺苷的假设
心肌梗死后巨噬细胞产生炎症介质,导致慢性心肌梗死。
炎症、成纤维细胞活化和纤维化。目标3:描述EN--的规模和后果
心肌梗死后重塑和缺血性心力衰竭期间腺苷生成增强。我们将评估变化
在心肌梗死后重建过程中存活心肌间质中腺苷的浓度-
英。我们假设腺苷的间质浓度在再灌注后期将逐渐增加。
建模为心力衰竭,用聚乙二醇化的腺苷脱氨酶治疗将其酶促清除
防护性的。这项工作的完成有望确定腺苷是一种重要的肝纤维化介质。
心脏通过与A2BAR亚型的相互作用促进心肌梗死后的病理重塑,
并可能为缺血性心脏病患者的治疗干预确定一个新的靶点。
英文摘要
ABSTRACT
The interstitial concentration of adenosine remains elevated following MI continuing well after the injured tissue
has healed and a scar has formed. However, the impact of adenosine signaling during post-MI remodeling
and chronic ischemic heart failure remains unknown. In other organs, the novel concept has emerged that
adenosine becomes damaging if it remains persistently elevated in tissues by activating pathways that promote
fibrosis. This has been observed in experimental animal models of chronic lung, liver, kidney, and skin diseas-
es. While the mechanisms by which adenosine becomes damaging vary, it generally acts to promote exces-
sive tissue repair via activation of the A2BAR. The A2BAR is a unique member of the AR family abundantly ex-
pressed in macrophages linked to cellular activation and production of inflammatory/fibrogenic cytokines. To
determine the contribution of adenosine signaling during post-MI remodeling, we examined the effect of genet-
ic deletion or blockade of the A2BAR (ATL-801) in a mouse model of permanent coronary artery ligation. Our
preliminary data show a marked reduction in fibrosis with loss of A2BAR signaling at 8 weeks post-MI, which
was associated with reduced inflammatory/fibrogenic activity in heart tissue, less dysfunction, and improved
compliance. Central hypothesis: Augmented production of adenosine persists following MI, which contributes
to fibrosis, pathological remodeling, and heart failure via activation of the A2BAR subtype. Aim #1 will define
the role of A2BAR signaling during post-MI remodeling. We will test whether genetic deletion or inhibition of the
A2BAR will slow the rate of fibrosis that develops in surviving myocardium following MI resulting in less dysfunc-
tion and ultimately prolonged survival. This aim will be accomplished using ATL-801, Adora2b-/- mice, as well
as a new line of Adora2b mutant rats created by our lab. Aim #2: To delineate the mechanisms by which
A2BAR signaling contributes to adverse post-MI remodeling. Utilizing a conditionally targeted mouse line lack-
ing expression of the A2BAR in myeloid-derived cells, assessments of macrophage infiltration/activation, and
molecular analyses of post-MI heart tissue, we will test the hypothesis that persistent exposure to adenosine
following MI stimulates the production of inflammatory mediators from macrophages that causes chronic in-
flammation, fibroblast activation, and fibrosis. Aim #3: To delineate the magnitude and consequences of en-
hanced adenosine production during post-MI remodeling and ischemic heart failure. We will assess changes
in the interstitial concentration of adenosine in the surviving myocardium during the course of post-MI remodel-
ing. We hypothesize that the interstitial concentration of adenosine will increase progressively during late re-
modeling as the heart fails and that its enzymatic removal with pegylated-adenosine deaminase therapy will be
protective. Completion of this work is expected to identify adenosine as an important fibrogenic mediator in the
heart that contributes to pathological remodeling following MI through its interaction with the A2BAR subtype,
and potentially identify a novel target for therapeutic intervention for patients with ischemic heart disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
EET-Induced Cardioprotection: Role of Opioids and Nitric Oxide (NO)
-
批准号:8431782
-
项目类别:
-
资助金额:$42.66万
-
财政年份:2012
-
负责人:JOHN A AUCHAMPACH
-
依托单位:
EET-Induced Cardioprotection: Role of Opioids and Nitric Oxide (NO)
-
批准号:8608431
-
项目类别:
-
资助金额:$43.84万
-
财政年份:2012
-
负责人:JOHN A AUCHAMPACH
-
依托单位:
Cardiovascular Physiology Core
-
批准号:7600701
-
项目类别:
-
资助金额:$22.36万
-
财政年份:2009
-
负责人:JOHN A AUCHAMPACH
-
依托单位:
Role of Adenosine Receptors in Tissue Protection
-
批准号:7388215
-
项目类别:
-
资助金额:$35.91万
-
财政年份:2005
-
负责人:JOHN A AUCHAMPACH
-
依托单位:
Role of Adenosine Receptors in Tissue Protection
-
批准号:7055253
-
项目类别:
-
资助金额:$36.98万
-
财政年份:2005
-
负责人:JOHN A AUCHAMPACH
-
依托单位:
Role of Adenosine Receptors in Tissue Protection
-
批准号:8040564
-
项目类别:
-
资助金额:$39.49万
-
财政年份:2005
-
负责人:JOHN A AUCHAMPACH
-
依托单位:
Role of Adenosine Receptors in Tissue Protection
-
批准号:8387001
-
项目类别:
-
资助金额:$37.11万
-
财政年份:2005
-
负责人:JOHN A AUCHAMPACH
-
依托单位:
Role of Adenosine Receptors in Tissue Protection
-
批准号:7587248
-
项目类别:
-
资助金额:$35.91万
-
财政年份:2005
-
负责人:JOHN A AUCHAMPACH
-
依托单位:
Role of Adenosine Receptors in Tissue Protection
-
批准号:7212061
-
项目类别:
-
资助金额:$35.91万
-
财政年份:2005
-
负责人:JOHN A AUCHAMPACH
-
依托单位:
Role of Adenosine Receptors in Tissue Protection
-
批准号:8588955
-
项目类别:
-
资助金额:$36.83万
-
财政年份:2005
-
负责人:JOHN A AUCHAMPACH
-
依托单位:
Role of Adenosine Receptors in Tissue Protection
-
批准号:6922340
-
项目类别:
-
资助金额:$37.88万
-
财政年份:2005
-
负责人:JOHN A AUCHAMPACH
-
依托单位:
Role of Adenosine Receptors in Tissue Protection
-
批准号:8208011
-
项目类别:
-
资助金额:$39.8万
-
财政年份:2005
-
负责人:JOHN A AUCHAMPACH
-
依托单位:
A3 RECEPTORS--CARDIOPROTECTIVE MECHANISMS
-
批准号:6448886
-
项目类别:
-
资助金额:$13.03万
-
财政年份:1998
-
负责人:JOHN A AUCHAMPACH
-
依托单位:
A3 RECEPTORS--CARDIOPROTECTIVE MECHANISMS
-
批准号:6476835
-
项目类别:
-
资助金额:$13.93万
-
财政年份:1998
-
负责人:JOHN A AUCHAMPACH
-
依托单位:
A3 Adenosine Receptors Cardioprotective Mechanisms
-
批准号:7195826
-
项目类别:
-
资助金额:$11.56万
-
财政年份:1998
-
负责人:JOHN A AUCHAMPACH
-
依托单位:
A3 RECEPTORS--CARDIOPROTECTIVE MECHANISMS
-
批准号:6625271
-
项目类别:
-
资助金额:$14.35万
-
财政年份:1998
-
负责人:JOHN A AUCHAMPACH
-
依托单位:
A3 Adenosine Receptors Cardioprotective Mechanisms
-
批准号:6874299
-
项目类别:
-
资助金额:$22.31万
-
财政年份:1998
-
负责人:JOHN A AUCHAMPACH
-
依托单位:
A3 Adenosine Receptors Cardioprotective Mechanisms
-
批准号:6775216
-
项目类别:
-
资助金额:$22.26万
-
财政年份:1998
-
负责人:JOHN A AUCHAMPACH
-
依托单位:
A3 RECEPTORS--CARDIOPROTECTIVE MECHANISMS
-
批准号:6125872
-
项目类别:
-
资助金额:$12.65万
-
财政年份:1998
-
负责人:JOHN A AUCHAMPACH
-
依托单位:
A3 RECEPTORS--CARDIOPROTECTIVE MECHANISMS
-
批准号:2751762
-
项目类别:
-
资助金额:$12.61万
-
财政年份:1998
-
负责人:JOHN A AUCHAMPACH
-
依托单位:
海外基金